| Arena Pharmaceuticals News (2003-2004) |
 |
| Thursday, June 12, 2008 |
| Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies Posted 3:36 PM PST |
| |
| Friday, June 6, 2008 |
| Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference Posted 2:23 PM PST |
| |
| Friday, May 9, 2008 |
| Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference Posted 6:24 AM PST |
| |
| Thursday, May 8, 2008 |
| Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference Posted 3:36 PM PST |
| |
| Monday, March 17, 2008 |
| Arena Pharmaceuticals' Lorcaserin for Obesity Passes Major Safety Milestone Posted 7:50 AM PST |
| |
| Thursday, March 13, 2008 |
| Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences Posted 7:52 AM PST |
| |
| Wednesday, February 6, 2008 |
| Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference Posted 8:44 AM PST |
| |
| Wednesday, January 30, 2008 |
| Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference Posted 8:15 AM PST |
| |
| Friday, January 25, 2008 |
| Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc. Posted 7:56 AM PST |
| |
| Wednesday, January 9, 2008 |
| Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial Posted 2:08 PM PST |
| |
| Monday, January 7, 2008 |
| Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes Posted 3:27 PM PST |
| |
| Thursday, January 3, 2008 |
| Arena Pharmaceuticals to Present at the 26th Annual JPMorgan Healthcare Conference Posted 9:16 AM PST |
| |
| Tuesday, December 18, 2007 |
| Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin Posted 6:02 AM PST |
| |
| Monday, December 17, 2007 |
| Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity Posted 7:40 AM PST |
| |
| Wednesday, December 12, 2007 |
| SAN DIEGO--- Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors Posted 3:19 PM PST |
| |
| Tuesday, November 20, 2007 |
| Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences Posted 7:53 AM PST |
| |
| Friday, November 2, 2007 |
| Arena Pharmaceuticals to Present at the CIBC World Markets 18th Annual Healthcare Conference Posted 6:40 AM PST |
| |
| Thursday, November 1, 2007 |
| Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock Posted 5:59 PM PST |
| |
| Wednesday, October 31, 2007 |
| Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference Posted 6:26 AM PST |
| |
| Monday, October 29, 2007 |
| Arena Pharmaceuticals to Present at the BIOCOM Investor Conference Posted 2:07 PM PST |
| |
| Wednesday, October 3, 2007 |
| Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences Posted 7:31 AM PST |
| |
| Wednesday, September 26, 2007 |
| Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index Posted 6:27 AM PST |
| |
| Tuesday, September 25, 2007 |
| Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia Posted 8:33 AM PST |
| |
| Friday, September 14, 2007 |
| Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences Posted 9:11 AM PST |
| |
| Tuesday, September 11, 2007 |
| Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review Posted 8:40 AM PST |
| |
| Wednesday, September 5, 2007 |
| Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference Posted 5:27 AM PST |
| |
| Friday, August 31, 2007 |
| Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference Posted 5:52 AM PST |
| |
| Wednesday, July 18, 2007 |
| Arena Pharmaceuticals Initiates Phase 1 Clinical Trial Program of APD791 for the Treatment of Arterial Thrombosis Posted 3:06 PM PST |
| |
| Tuesday, June 12, 2007 |
| SAN DIEGO--- Jack Lief Named Chairman of ADVENTRX Pharmaceuticals Posted 9:16 AM PST |
| |
| Wednesday, May 30, 2007 |
| SAN DIEGO--- BioDuro, LLC Announces Appointment of Nigel R. A. Beeley, Ph.D., as CEO, China Operations Posted 7:43 AM PST |
| |
| Wednesday, April 18, 2007 |
| Arena Pharmaceuticals Announces First Quarter 2007 Financial Results Posted 4:21 PM PST |
| |
| Monday, March 5, 2007 |
| Arena Pharmaceuticals Initiates Phase 2 Clinical Trial of APD125 for the Treatment of Insomnia Posted 8:05 AM PST |
| |
| Wednesday, February 14, 2007 |
| Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2006 Financial Results and to Host Conference Call and Webcast on Wednesday, February 21, 2007 Posted 7:48 AM PST |
| |
| Monday, February 5, 2007 |
| Arena Pharmaceuticals Completes Enrollment with 3,182 Patients in Lorcaserin Phase 3 BLOOM Trial for Obesity Posted 7:15 AM PST |
| |
| Wednesday, December 13, 2006 |
| Arena Pharmaceuticals Announces Completion of Common Stock Offering Posted 4:46 PM PST |
| |
| Friday, December 8, 2006 |
| Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock Posted 8:12 AM PST |
| |
| Tuesday, November 28, 2006 |
| SAN DIEGO--- Arena Pharmaceuticals Announces Public Offering of Common Stock Posted 4:09 PM PST |
| |
| Thursday, November 9, 2006 |
| ADVENTRX Announces 2006 Third Quarter Financial Results Posted 4:04 PM PST |
| |
| Wednesday, October 25, 2006 |
| Arena Pharmaceuticals Announces Third Quarter 2006 Financial Results Posted 3:52 PM PST |
| |
| Wednesday, October 18, 2006 |
| Arena Pharmaceuticals to Report Third Quarter 2006 Financial Results and to Host Conference Call and Webcast on Wednesday, October 25, 2006 Posted 8:00 AM PST |
| |
| Wednesday, September 27, 2006 |
| Arena Pharmaceuticals Announces That Ortho-McNeil Extends Research Term Under Partnership to Develop Drugs to Treat Type 2 Diabetes Posted 7:05 AM PST |
| |
| Monday, September 25, 2006 |
| Arena Pharmaceuticals Announces Update on Partnership With Merck in Development of Niacin Receptor Agonists Posted 3:00 PM PST |
| |
| Friday, September 22, 2006 |
| SAN DIEGO--- ADVENTRX Appoints Jack Lief as Director Posted 7:00 AM PST |
| |
| Friday, September 15, 2006 |
| Kintera Tops Deloitte's San Diego Technology Fast 50 Ranking of Fastest-Growing Companies, With 14,159 Percent Revenue Growth Over Five Years Posted 3:58 PM PST |
| |
| Monday, August 14, 2006 |
| SAN DIEGO--- Arena Pharmaceuticals Appoints Christine A. White, M.D. to Board of Directors Posted 7:15 AM PST |
| |
| Tuesday, July 25, 2006 |
| Arena Pharmaceuticals Announces Second Quarter 2006 Financial Results Posted 2:27 PM PST |
| |
| Tuesday, July 18, 2006 |
| Arena Pharmaceuticals to Report Second Quarter 2006 Financial Results and to Host Conference Call and Webcast on Tuesday, July 25, 2006 Posted 7:47 AM PST |
| |
| Thursday, June 1, 2006 |
| BIOCOM Announces Annual Life Science Award Winners and New Board Members Posted 7:06 AM PST |
| |
| Thursday, May 18, 2006 |
| Arena Pharmaceuticals Announces Achievement of Phase 2 Clinical Milestone Under Cardiovascular Disease Collaboration With Merck Posted 4:23 PM PST |
| |
| Monday, May 8, 2006 |
| Arena Pharmaceuticals Announces First Quarter 2006 Financial Results Posted 3:55 PM PST |
| |
| Friday, May 5, 2006 |
| USAN Council Approves Nonproprietary Name Lorcaserin Hydrochloride for Arena Drug Candidate APD356 Posted 7:02 AM PST |
| |
| Wednesday, March 29, 2006 |
| Arena Pharmaceuticals Provides APD356 Obesity and APD125 Insomnia Clinical Program Updates Posted 7:30 AM PST |
| |
| Wednesday, February 22, 2006 |
| Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2005 Financial Results Posted 3:07 PM PST |
| |
| Thursday, February 16, 2006 |
| Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2005 Financial Results and to Host Conference Call and Webcast on Wednesday, February 22, 2006 Posted 4:31 PM PST |
| |
| Tuesday, February 7, 2006 |
| Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Arena Type 2 Diabetes Drug Candidate in Collaboration With Ortho-McNeil Posted 3:55 PM PST |
| |
| Thursday, February 2, 2006 |
| Arena Pharmaceuticals Announces Exercise of Over-Allotment Option by Underwriters Posted 3:34 PM PST |
| |
| Friday, January 27, 2006 |
| Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock Posted 7:54 AM PST |
| |
| Tuesday, January 3, 2006 |
| SAN DIEGO--- Arena Pharmaceuticals Appoints Robert E. Hoffman as Chief Financial Officer Posted 4:25 PM PST |
| |
| Monday, January 2, 2006 |
| Arena Pharmaceuticals Issued Patent for 5-HT2A Receptor Modulators by European Patent Office Posted 7:58 AM PST |
| |
| Arena Pharmaceuticals Announces Anti-thrombosis Program to Be Advanced Into Preclinical Development Posted 7:56 AM PST |
| |
| Tuesday, December 13, 2005 |
| Arena Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results of Novel Anti-Obesity Compound Posted 4:07 PM PST |
| |
| Monday, December 12, 2005 |
| Arena Pharmaceuticals' APD356 Selected as Winner of CONNECT's Most Innovative New Product Award in the Biotechnology Research and Development Category Posted 3:26 PM PST |
| |
| Friday, December 9, 2005 |
| SAN DIEGO--- CONNECT Announces Winners of 2005 Most Innovative New Product Awards; San Diego Technology and Life Science Companies Honored for Their Excellence in Creative Applications and Product Development Posted 4:56 PM PST |
| |
| Tuesday, October 18, 2005 |
| Arena's APD356 Phase 2a Clinical Trial Data Presented at the 2005 NAASO Annual Meeting Posted 5:02 PM PST |
| |
| Monday, October 17, 2005 |
| Arena Pharmaceuticals Announces Third Quarter 2005 Financial Results Posted 5:39 PM PST |
| |
| Tuesday, October 11, 2005 |
| Arena Pharmaceuticals Issued Patent for 5-HT2C Receptor Modulators by United States Patent Office Posted 4:40 PM PST |
| |
| Monday, October 10, 2005 |
| Arena Pharmaceuticals to Announce Third Quarter 2005 Financial Results and to Host Conference Call and Webcast on Monday, October 17, 2005 Posted 5:26 PM PST |
| |
| Friday, October 7, 2005 |
| SAN DIEGO--- CONNECT Announces 2005 Most Innovative New Product (MIP) Awards Finalists; San Diego Technology and Life Science Companies Continue to Demonstrate Excellence in Creative Applications and Product Development Posted 5:09 PM PST |
| |
| Thursday, September 1, 2005 |
| Arena Pharmaceuticals to Present at Five Investor Conferences in September 2005 Posted 9:09 AM PST |
| |
| Thursday, August 25, 2005 |
| Arena Pharmaceuticals Announces Assessment of Echocardiograms Indicates No Apparent APD356 Effect on Heart Valves or Pulmonary Artery Pressure in Phase 2a Trial Posted 9:05 AM PST |
| |
| Monday, August 15, 2005 |
| FOSTER CITY--- Former Genentech CFO to Join Equinix Board of Directors Posted 10:00 AM PST |
| |
| Thursday, August 11, 2005 |
| Arena Pharmaceuticals Granted Patent for Drug Screening Methods Related to Ortho McNeil, Inc. Collaboration Posted 7:20 PM PST |
| |
| Tuesday, July 19, 2005 |
| Arena Pharmaceuticals Announces Second Quarter 2005 Financial Results Posted 9:05 AM PST |
| |
| Thursday, June 23, 2005 |
| Arena Pharmaceuticals Announces Initiation of Phase 2b Clinical Trial of Its Novel Anti-Obesity Compound Posted 9:15 AM PST |
| |
| Friday, June 17, 2005 |
| Arena Pharmaceuticals to Present at the Biotechnology Industry Organization 2005 Annual International Convention Posted 5:14 PM PST |
| |
| Arena Pharmaceuticals to Present Abstract on APD125, a Novel Drug Candidate for the Treatment of Insomnia Posted 9:16 AM PST |
| |
| Thursday, May 26, 2005 |
| Arena Pharmaceuticals to Webcast Analyst and Investor Day on June 2, 2005 Posted 5:54 PM PST |
| |
| Thursday, May 19, 2005 |
| Arena Pharmaceuticals to Present at the Fourth Annual Needham Biotechnology Conference Posted 5:41 PM PST |
| |
| Wednesday, May 4, 2005 |
| Arena Pharmaceuticals Issued Patent for 5-HT2C Receptor Modulators by European Patent Office Posted 4:30 PM PST |
| |
| Tuesday, April 26, 2005 |
| Arena Pharmaceuticals Announces First Quarter 2005 Financial Results Posted 7:38 PM PST |
| |
| Wednesday, April 13, 2005 |
| Arena Pharmaceuticals to Announce First Quarter 2005 Financial Results on Tuesday, April 26, 2005, and to Host Conference Call and Webcast on Wednesday, April 27, 2005 Posted 5:10 PM PST |
| |
| Thursday, March 24, 2005 |
| SAN DIEGO--- BIOCOM Announces New Board Officers and Board Members Posted 5:49 PM PST |
| |
| Thursday, February 10, 2005 |
| Arena Pharmaceuticals to Announce Fourth Quarter and Full Year of 2004 Financial Results on Wednesday, February 16, 2005, and to Host Conference Call and Webcast on Thursday, February 17, 2005 Posted 11:03 AM PST |
| |
| Tuesday, February 8, 2005 |
| Arena Pharmaceuticals Announces Exercise of Over-Allotment Option By Underwriters Posted 7:22 PM PST |
| |
| Tuesday, February 1, 2005 |
| Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock Posted 10:56 AM PST |
| |
| Tuesday, January 18, 2005 |
| SAN DIEGO--- Arena Pharmaceuticals Appoints Louis J. Lavigne, Jr. To the Company's Board of Directors Posted 9:05 PM PST |
| |
| Thursday, January 13, 2005 |
| SAN DIEGO--- Arena Pharmaceuticals Announces Public Offering of Common Stock Posted 8:38 AM PST |
| |
| Thursday, December 23, 2004 |
| Arena Pharmaceuticals Announces Selection of Two Arena-Discovered Compounds for Preclinical Development by Ortho-McNeil Posted 9:49 AM PST |
| |
| Wednesday, December 22, 2004 |
| Arena Pharmaceuticals Initiates Phase 2 Efficacy Study for Its Novel Anti-Obesity Compound Posted 9:31 AM PST |
| |
| Tuesday, December 21, 2004 |
| Arena Pharmaceuticals Announces Global Diabetes Collaboration with Ortho-McNeil Pharmaceutical Posted 9:29 AM PST |
| |
| Tuesday, August 10, 2004 |
| Arena Pharmaceuticals Announces Achievement of a $3 Million Milestone Under Merck Collaboration Posted 7:40 AM PST |
| |
| Monday, July 26, 2004 |
| Arena Pharmaceuticals Initiates Phase 1b Clinical Trial of Novel Anti-Obesity Drug Posted 8:36 AM PST |
| |
| Tuesday, July 20, 2004 |
| Arena Pharmaceuticals Announces Second Quarter 2004 Financial Results Posted 6:58 PM PST |
| |
| Wednesday, July 14, 2004 |
| Arena Pharmaceuticals Reports Successful Phase 1a Safety and Clinical Pharmacology Trial Results of Novel Anti-Obesity Compound Posted 8:26 AM PST |
| |
| Thursday, July 1, 2004 |
| Arena Pharmaceuticals to Announce Second Quarter 2004 Financial Results and to Host Conference Call and Webcast on Tuesday, July 20, 2004 Posted 6:17 PM PST |
| |
| Thursday, May 6, 2004 |
| Arena Pharmaceuticals to Present Corporate Update at the Rodman & Renshaw Techvest Global Healthcare Conference Posted 8:49 AM PST |
| |
| Wednesday, April 21, 2004 |
| Arena Pharmaceuticals Announces First Quarter 2004 Financial Results Posted 9:12 AM PST |
| |
| Tuesday, April 13, 2004 |
| Arena Pharmaceuticals to Announce First Quarter 2004 Financial Results on Tuesday, April 20, 2004, and to Host Conference Call and Webcast on Wednesday, April 21, 2004 Posted 9:38 AM PST |
| |
| Wednesday, March 17, 2004 |
| SAN DIEGO--- Arena Pharmaceuticals Announces Management Changes Posted 8:40 AM PST |
| |
| Wednesday, February 25, 2004 |
| Arena Pharmaceuticals Announces Achievement of $4 Million Success Milestone Under Merck Collaboration Posted 8:34 AM PST |
| |
| Tuesday, February 24, 2004 |
| Arena Pharmaceuticals Initiates Clinical Trial of Novel Anti-Obesity Drug Posted 9:16 AM PST |
| |
| Tuesday, January 20, 2004 |
| Arena Pharmaceuticals Announces Financial Results for the Fourth Quarter And Full Year of 2003 Posted 4:33 PM PST |
| |
| Thursday, January 8, 2004 |
| Arena Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year of 2003 Earnings Release Date and Conference Call Posted 9:09 AM PST |
| |
| Monday, January 5, 2004 |
| Arena Pharmaceuticals Announces Resignation of Chief Financial Officer Posted 6:13 PM PST |
| |
| Monday, December 29, 2003 |
| Arena Pharmaceuticals Completes $35 Million Private Placement Posted 8:52 AM PST |
| |
| Tuesday, December 16, 2003 |
| SAN DIEGO--- Arena Pharmaceuticals Strengthens Board by Appointing Three New Directors And An Advisory Director; Achieves Majority Outside Directors Posted 5:46 PM PST |
| |
| Monday, December 15, 2003 |
| Arena Pharmaceuticals Announces Successful Completion of Preclinical Studies On Its Novel Obesity Compound and Restructuring as it Prepares to Initiate Clinical Development in the First Quarter 2004 Posted 7:42 PM PST |
| |
| Tuesday, November 4, 2003 |
| ALAMEDA--- As the European Biotech Industry Catches Up, California Biotech Companies Increasingly Seek European Partners Posted 8:32 AM PST |
| |
| Wednesday, October 22, 2003 |
| Arena Pharmaceuticals Reports 2003 Third Quarter and Nine Months Results Posted 4:40 PM PST |
| |
| Monday, October 20, 2003 |
| Arena Pharmaceuticals Purchases Stock From Largest Stockholder Posted 11:50 AM PST |
| |
| Wednesday, October 8, 2003 |
| Arena Pharmaceuticals Offers to Purchase Three Million Shares Owned By Its Largest Stockholder at 90% of Market Value And Amends Stockholders Agreement With the Stockholder Posted 4:40 PM PST |
| |
| Thursday, May 1, 2003 |
| Arena Pharmaceuticals Receives U.S. Patent for One of Its Core GPCR Technologies Posted 8:06 AM PST |
| |
| Wednesday, April 23, 2003 |
| Arena Pharmaceuticals Announces Financial Results for the First Quarter of 2003 Posted 2:59 PM PST |
| |
| Friday, April 11, 2003 |
| Arena Pharmaceuticals, Inc. Announces First Quarter 2003 Earnings Release Date and Conference Call Posted 5:54 PM PST |
| |
| Wednesday, January 8, 2003 |
| Arena Pharmaceuticals, Inc. Reschedules Fourth Quarter Earnings Conference Call to Tuesday, January 21, 2003 at 9:00 A.M. Eastern Time Posted 2:39 PM PST |
| |
